Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin

Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-50
SponsorGoldman, Butterwick, Fitzpatrick and Groff

About this trial

The primary objective of this study is to assess the efficacy and safety of combination therapy of BABOR® Ultimate ECM Repair Serum and the BABOR® Cure Cream for the improvement of anti-aging through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Men and women between the ages of 18 and 50 years old (inclusive).

Subjects must be able and willing to provide written informed consent and photography release.

Class I-II of Wrinkling on the Fitzpatrick-Goldman Classification of Wrinkling and Degree of Elastosis Scale

Score 1-6 of Degree of Elastosis on the Fitzpatrick-Goldman Classification of Wrinkling and Degree of Elastosis Scale

Disqualifiers

Subjects who are pregnant, planning pregnancy during the course of the study, or breastfeeding.

Subjects with an active bacterial, fungal, or viral infection in the treatment area

Subjects with a significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.

Subjects receiving any topical products containing tretinoins or derivatives, alpha-hydroxy acids, salicylic acid, and vitamins C or E (includes derivatives thereof) on the face within 14 days prior to or during the study period, other than the study products.

Trial design

Design model

Single group

Treatments tested in this trial

  • Babor Ultimate ECM Repair Serum

    Drug

    The BABOR® Ultimate ECM Repair Serum contains Biogen plant extract, cotton thistle flower, and wakame extract. Babor products are encouraged to be used simultaneously mornings and/or evenings to reinforce the skin's protective barrier, promote vibrant skin, and restore skin elasticity and firmness.

  • Babor Cure Cream

    Drug

    Babor products are encouraged to be used simultaneously mornings and/or evenings to reinforce the skin's protective barrier, promote vibrant skin, and restore skin elasticity and firmness.

Treatment groups

18 Participants
are divided into 1 treatment group
Group A: Babor ProductsExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Fitzpatrick- Goldman Classification of Wrinkling and Degree of Elastosis Scale

Circle appropriate class: Class one: Mild Fine Wrinkles 1-2-3 Class two: Moderate Wrinkles 4-5-6 Class three: Severe Wrinkles 7-8-9

Time frame
Screening, Day 60, Day 90
2

Evaluating Investigator Expert Grading Scales

Redness/ Erythema: None (Score of 0) No erythema or redness of the treatment area Mild (Score of 1, 2 or 3) Slight, but definite redness of the treatment area Moderate (Score of 4, 5 or 6) Definite redness of the treatment area Severe (Score of 7, 8 or 9) Marked redness of the treatment area Dryness/ Scaling/Roughness: None (Score of 0) No dryness, roughness, or flaking/scaling of the treatment area Mild (Score of 1, 2 or 3) Slight, but definite roughness, some areas of light visible flaking/scaling of the treatment area Moderate (Score of 4, 5 or 6) Definite roughness and areas of visible flaking/scaling of the treatment area Severe (Score of 7, 8 or 9) Marked roughness and areas of visible flaking/scaling of the treatment area

Time frame
Screening, Day 30, Day 60, Day 90
3

Evaluating Investigator Expert Grading Scales (part 2)

Luminosity: None (Score of 0) Radiant, luminous or glowing appearance Mild (Score of 1, 2 or 3) Some areas of dullness or matte skin in the treatment area Moderate (Score of 4, 5 or 6) Several areas of dullness or matte skin in the treatment area Severe (Score of 7, 8 or 9) Dull/matte and/or sallow skin appearance

Time frame
Screening, Day 30, Day 60, Day 90

Secondary outcomes

1

Evaluating Investigator Tolerability Assessment

Stinging/ Burning: None (Score of 0) No stinging/burning of the treatment area Mild (Score of 1, 2 or 3) Slight, but definite stinging/burning of the treatment area Moderate (Score of 4, 5 or 6) Definite stinging/burning of the treatment area Severe (Score of 7, 8 or 9) Marked stinging/burning of the treatment area Itching: None (Score of 0) No itching of the treatment area. Mild (Score of 1, 2 or 3) Slight, but definite itching of the treatment area. Moderate (Score of 4, 5 or 6) Definite itching of the treatment area that is distracting from daily activities. Severe (Score of 7, 8 or 9) Marked itching of the treatment area that wakes you up at night. Rash: None (Score of 0) No new rash over the treatment area. Mild (Score of 1, 2 or 3) New rash covering some of the treatment area. Moderate (Score of 4, 5 or 6) New rash covering much of the treatment area. Severe (Score of 7, 8 or 9) New rash covering the entirety of the treatment area.

Time frame
Screening, Day 30, Day 60, Day 90
2

Subject Self-Assessment Questionnaire (part 1)

1. Skincare regimen helps reduce the wrinkles of my facial skin. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 2. Skincare regimen helps reduce the dryness of my facial skin. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 3. Cleanser/moisturizer regimen helps decrease the dullness of my facial skin. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 4. Skincare regimen helps reduce the unevenness of my facial skin. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 5. Skincare regimen leaves my facial skin radiant/brighter. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly

Time frame
Screening, Day 30, Day 60, Day 90
3

Subject Self-Assessment Questionnaire (part 2)

6\. Skincare regimen leaves my facial skin softer. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 7. Skincare regimen leaves my facial skin smoother. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 8. Skincare regimen is gentle. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 9. Skincare regimen leaves my facial skin healthy looking. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 10. Skincare regimen helps reduce the flakiness of my skin. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly

Time frame
Screening, Day 30, Day 60, Day 90
4

Subject Self-Assessment Questionnaire (part 3)

11\. I now understand the importance of a consistent skincare routine. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 12. I feel more confident about the appearance of my facial skin. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 13. Using this skincare regimen makes me optimistic about my appearance. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 14. This skincare regimen was easy to follow. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly 15. It was easy to adhere to this skincare routine. Agree Strongly Agree Neither agree nor disagree Disagree Disagree Strongly

Time frame
Screening, Day 30, Day 60, Day 90

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: